Avotaciclib hydrochloride, a CDK1 inhibitor, is the hydrochloride salt of Avotaciclib and exhibits potential therapeutic use in specific malignancies, including pancreatic cancer, characterized by abnormal and pronounced CDK1 expression [1].
Molecular Weight:
317.73
Formula:
C13H12ClN7O
Target:
BEY1107 hydrochloride
* VAT and and shipping costs not included. Errors and price changes excepted
